Protein C Promotor Haplotypes Associated with Large-Artery Atherosclerosis Stroke in Iranian Population

Seyed Elyas Meshkani1, Ali Fasihi2, Fatemeh Badakhshan3

  • 1Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.

Insights

Genetic variations in Protein C (PC) influence ischemic stroke (IS) risk. Specific single-nucleotide polymorphisms (SNPs) in the PC promoter were found to be more common in Iranian IS patients, suggesting a genetic link.

Area of Science:

  • Genetics
  • Cardiovascular Science
  • Molecular Biology

Background:

  • Ischemic stroke (IS) is a complex condition with numerous risk factors, including genetic predispositions.
  • Protein C (PC), an essential antithrombotic enzyme, plays a crucial role in regulating blood coagulation.
  • Genetic variations in PC can disrupt coagulation pathways, potentially leading to thrombosis and increasing stroke risk.

Purpose of the Study:

  • To investigate the association between three single-nucleotide polymorphisms (SNPs) in the core promoter of the Protein C gene and the risk of ischemic stroke in the Iranian population.
  • To explore the potential functional impact of these SNPs on PC gene expression and their role in IS pathogenesis.

Main Methods:

  • Blood samples were collected from ischemic stroke patients (n=249) and healthy controls (n=203).
  • Biochemical analyses were performed, and DNA was extracted for genotyping using the High-Resolution Melting (HRM) technique.
  • Bioinformatic analyses were employed to predict the functional consequences of identified SNPs on transcription factor binding and gene expression.

Main Results:

  • Significant differences in smoking status, hypertension, LDL cholesterol, and fasting blood glucose were observed between IS patients and controls.
  • Two SNPs, rs1799809 and rs1799810, were found to be significantly more prevalent in the IS patient group.
  • The CGT haplotype was significantly associated with an increased risk of ischemic stroke (p=0.001).

Conclusions:

  • Specific SNPs in the Protein C core promoter are associated with an increased risk of ischemic stroke in the Iranian population.
  • These genetic variations may alter transcription factor binding affinity, leading to reduced PC expression and consequently elevating the risk of IS.
  • The findings highlight the importance of genetic factors, particularly variations in the PC gene, in the etiology of ischemic stroke.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
644
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
143
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.9K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
111
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
347
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
326